retatrutide triple agonist glp-1 gip glucagon phase 3 2025

retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Retatrutide (4 x 10mg Vial) Retatrutide is a triple-agonist drug

Name: retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Retatrutide (4 x 10mg Vial) Retatrutide is a triple-agonist drug
Brand: roaa.app
SKU: 5172059025
Price: 21.77 USD
Availability: InStock
Rating: 4.7011 (7 reviews)

SKU: 5172059025

4.7

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

Retatrutide activates 3 receptors (GLP-1, GIP, glucagon) to reduce appetite, improve metabolism, and burn fat

Its an excellent antioxidant, providing critical protection against oxidative stress while supporting optimal brain function

Discontinuation due to adverse events runs approximately 4-7% across studies, which is comparable to other GLP-1 receptor agonists

Estradiol, FSH, thyroid panel, fasting insulin, IGF-1, vitamin D, and a complete metabolic panel

Liver-specific BMP4 expression reduces lipid accumulation and MASLD progression via the mammalian target of rapamycin complex (mTORC) 1 pathway (Peng et al